(HealthDay)—An estimated 14.3 percent of the U.S. population were infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by mid-November 2020, according to a study published online Jan. 5 in ...
Jan 5, 2021
0
11
Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection. New research led by investigators at Massachusetts General Hospital ...
Dec 23, 2020
0
31
As dozens of countries blocked the flow of people and goods from Britain to avoid a new and more contagious strain of coronavirus, scientists raced to understand how it emerged and the scope of its threat.
Dec 22, 2020
0
3
National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or "nanobodies," against SARS-CoV-2 that were produced by a llama named Cormac. Preliminary results published in Scientific Reports ...
Dec 22, 2020
0
64
(HealthDay)—An interim analysis of data from an ongoing phase 1 to 3 trial shows that an antibody cocktail enhances clearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, according to a study published ...
Dec 21, 2020
0
2
The researchers Wasco Wruck and Prof. James Adjaye from the Institute of Stem Cell Research and Regenerative Medicine, Medical Faculty of Heinrich-Heine-University Duesseldorf, Germany, employed a bioinformatic approach on ...
Dec 21, 2020
0
6
Highly promising vaccines have recently emerged for COVID-19, but this doesn't mean research into other treatments can slow down. There is still no cure for the disease, and people will likely continue to get sick even after ...
Dec 21, 2020
0
0
The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified a specific genetic target that could help explain the tremendous variation in how sick those infected with COVID-19 become.
Dec 16, 2020
0
9
What does SARS-CoV-2, the virus that causes COVID-19, do once it enters a person's airways, and how does infection in lung cells affect patients' immune responses? New research led by investigators at Massachusetts General ...
Dec 16, 2020
1
362
A study tracking seroprevalence across Iran suggests that the number of people who have had the SARS-CoV-2 virus is 17.1% overall and 20.0% in high-risk occupations. The findings suggest that an estimated almost 4.3 million ...
Dec 16, 2020
0
2
